BioRestorative Therapies Company Profile (NASDAQ:BRTX)

About BioRestorative Therapies

BioRestorative Therapies logoBioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The Company offers human and plant stem cell derived cosmetic and skin care products. Its programs relate to the treatment of disc/spine disease and metabolic disorders and include Disc/Spine Program (brtxDISC) and Metabolic Program (ThermoStem). Its curved needle device (CND) is a needle system with a curved inner cannula to allow access to difficult-to-locate regions for the delivery or removal of fluids and other substances. The CND is intended to deliver stem cells and/or other therapeutic products or material to the interior of a human intervertebral disc, the spine region, or other areas of the body. The device relies on the use of pre-curved nested cannulae that allows the cells or material to be deposited in the posterior and lateral aspects of the disc to which direct access is not possible due to outlying structures.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BRTX
  • CUSIP:
Key Metrics:
  • Previous Close: $4.65
  • 50 Day Moving Average: $4.06
  • 200 Day Moving Average: $3.45
  • 52-Week Range: $2.71 - $5.01
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $21.19M
Additional Links:

Analyst Ratings

Consensus Ratings for BioRestorative Therapies (NASDAQ:BRTX) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for BioRestorative Therapies (NASDAQ:BRTX)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for BioRestorative Therapies (NASDAQ:BRTX)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for BioRestorative Therapies (NASDAQ:BRTX)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for BioRestorative Therapies (NASDAQ:BRTX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for BioRestorative Therapies (NASDAQ:BRTX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/26/2016John M DesmaraisDirectorBuy80,000$3.00$240,000.00View SEC Filing  
5/18/2016Robert B CatellDirectorBuy12,500$4.00$50,000.00View SEC Filing  
3/18/2016John M DesmaraisDirectorBuy250,000$4.00$1,000,000.00View SEC Filing  
3/1/2016Robert B CatellDirectorBuy37,500$4.00$150,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for BioRestorative Therapies (NASDAQ:BRTX)
DateHeadline
marketexclusive.com logoBIORESTORATIVE THERAPIES, INC. (OTCMKTS:BRTX) Files An 8-K Unregistered Sales of Equity Securities (NASDAQ:BRTX)
marketexclusive.com - February 16 at 8:52 AM
biz.yahoo.com logoBIORESTORATIVE THERAPIES, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Change in Directors or Pri (NASDAQ:BRTX)
biz.yahoo.com - February 14 at 9:42 PM
News IconRegenexx Licensed Disc Technology Gets FDA Approval for Phase 2 Trial (NASDAQ:BRTX)
www.regenexx.com - February 9 at 4:19 PM
biz.yahoo.com logoBIORESTORATIVE THERAPIES, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities (NASDAQ:BRTX)
biz.yahoo.com - February 8 at 4:16 PM
finance.yahoo.com logoBioRestorative Therapies Receives FDA Clearance to Initiate Phase 2 Clinical Trial for the Treatment of Patients with Degenerative Disc Disease (NASDAQ:BRTX)
finance.yahoo.com - February 8 at 4:16 PM
News IconBioRestorative Therapies Inc BRTX Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:BRTX)
www.bioportfolio.com - January 13 at 2:19 AM
us.rd.yahoo.com logo9:46 am BioRestorative Therapies submits an Investigational New Drug Application to the FDA to seek clearance to commence a clinical trial using its lead cell therapy candidate, BRTX-100, to treat chronic lower back pain due to degenerative (NASDAQ:BRTX)
us.rd.yahoo.com - January 9 at 10:09 PM
News IconBioRestorative Therapies Submits IND Application to FDA to Treat Patients with Degenerative Disc Disease (NASDAQ:BRTX)
www.otcmarkets.com - January 9 at 5:06 PM
capitalcube.com logoBioRestorative Therapies, Inc. :BRTX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016 (NASDAQ:BRTX)
www.capitalcube.com - November 18 at 12:39 PM
News IconBioRestorative Therapies, Inc. BRTX Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:BRTX)
www.bioportfolio.com - November 17 at 1:38 PM
biz.yahoo.com logoBIORESTORATIVE THERAPIES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:BRTX)
biz.yahoo.com - October 20 at 8:51 PM
globenewswire.com logoNo Adverse Events and Overall Improvement Reported by Study Patients (NASDAQ:BRTX)
globenewswire.com - September 13 at 8:49 AM
finance.yahoo.com logoBioRestorative Therapies Announces Publication in Medical Journal of Positive Results of Long-Term Safety and Feasibility Study Using Cell Therapy to Treat Patients with Degenerative Disc Disease (NASDAQ:BRTX)
finance.yahoo.com - September 12 at 3:51 PM
finance.yahoo.com logo9:46 am BioRestorative Therapies announces publication in Medical Journal of results of long-term safety and feasibility study using cell therapy to treat patients with degenerative disc disease (NASDAQ:BRTX)
finance.yahoo.com - September 12 at 3:51 PM
4-traders.com logoBioRestorative Therapies : Announces Presentation at 3rd Annual Regenerative Medicine Essentials Course (NASDAQ:BRTX)
www.4-traders.com - July 15 at 2:33 PM
finance.yahoo.com logoBioRestorative Therapies Announces Presentation at 3rd Annual Regenerative Medicine Essentials Course (NASDAQ:BRTX)
finance.yahoo.com - July 13 at 10:47 AM
biz.yahoo.com logoBIORESTORATIVE THERAPIES, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under a (NASDAQ:BRTX)
biz.yahoo.com - June 30 at 4:36 PM
einnews.com logoData Collected Showed No Adverse Events (NASDAQ:BRTX)
www.einnews.com - June 28 at 4:08 PM
finance.yahoo.com logoBioRestorative Therapies Announces Completion of Human Safety and Feasibility Study on the Use of Hypoxic Cultured Stem Cells to Treat Chronic Lower Back Pain (NASDAQ:BRTX)
finance.yahoo.com - June 28 at 9:45 AM
biz.yahoo.com logoBIORESTORATIVE THERAPIES, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:BRTX)
biz.yahoo.com - June 2 at 6:02 AM
finance.yahoo.com logoBioRestorative Therapies to Present at 5th Annual Marcum MicroCap Conference (NASDAQ:BRTX)
finance.yahoo.com - May 31 at 9:45 AM
4-traders.com logoBioRestorative Therapies : Announces Promising Data to Advance its Program for the Treatment of Metabolic Disorders (NASDAQ:BRTX)
www.4-traders.com - May 24 at 4:57 PM
finance.yahoo.com logoBioRestorative Therapies Announces Promising Data to Advance its Program for the Treatment of Metabolic Disorders (NASDAQ:BRTX)
finance.yahoo.com - May 23 at 9:45 AM
biz.yahoo.com logoBIORESTORATIVE THERAPIES, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:BRTX)
biz.yahoo.com - May 13 at 5:39 PM
biz.yahoo.com logoBIORESTORATIVE THERAPIES, INC. Files SEC form 10-K, Annual Report (NASDAQ:BRTX)
biz.yahoo.com - March 30 at 5:35 PM
biz.yahoo.com logoBIORESTORATIVE THERAPIES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of E (NASDAQ:BRTX)
biz.yahoo.com - March 24 at 11:55 AM
biz.yahoo.com logoBIORESTORATIVE THERAPIES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial (NASDAQ:BRTX)
biz.yahoo.com - February 24 at 1:53 PM
biz.yahoo.com logoBIORESTORATIVE THERAPIES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Change in Dir (NASDAQ:BRTX)
biz.yahoo.com - December 28 at 11:22 AM
finance.yahoo.com logoBioRestorative Therapies Provides Company Updates With Shareholder Letter (NASDAQ:BRTX)
finance.yahoo.com - December 21 at 8:00 AM
finance.yahoo.com logoBIORESTORATIVE THERAPIES, INC. Financials (NASDAQ:BRTX)
finance.yahoo.com - December 8 at 1:18 PM
finance.yahoo.com logoBioRestorative Therapies, Inc. Announces Opening of New Headquarters and Laboratory Facility in New York (NASDAQ:BRTX)
finance.yahoo.com - April 14 at 7:45 AM
finance.yahoo.com logoBioRestorative Therapies Appoints Charles S. Ryan, J.D., Ph.D. to its Board of Directors (NASDAQ:BRTX)
finance.yahoo.com - April 8 at 8:52 AM

Social

What is BioRestorative Therapies' stock symbol?

BioRestorative Therapies trades on the NASDAQ under the ticker symbol "BRTX."

How do I buy BioRestorative Therapies stock?

Shares of BioRestorative Therapies can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of BioRestorative Therapies stock cost?

One share of BioRestorative Therapies stock can currently be purchased for approximately $4.65.

BioRestorative Therapies (NASDAQ:BRTX) Chart for Monday, February, 20, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for BioRestorative Therapies (NASDAQ:BRTX)

Earnings History Chart

Earnings by Quarter for BioRestorative Therapies (NASDAQ:BRTX)

Dividend History Chart

Dividend Payments by Quarter for BioRestorative Therapies (NASDAQ:BRTX)

Last Updated on 2/20/2017 by MarketBeat.com Staff